The effect of low and high dose empagliflozin on HbA1c and lipid profile in type 2 diabetes mellitus: A real-world data

OBJECTIVE: This study aims to evaluate the efficacy and safety of the addition of 10 or 25 mg of empagliflozin to patients with type 2 diabetes mellitus using a maximum tolerable dose of metformin and gliclazide. METHODS: A total of 60 patients who had been receiving a maximum tolerable dose of metf...

Full description

Bibliographic Details
Main Authors: Serhat Özçelik, Mehmet Çelik, Aşkı Vural, Bünyamin Aydın
Format: Article
Language:English
Published: KARE Publishing 2020-03-01
Series:İstanbul Kuzey Klinikleri
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=nci&un=NCI-22697

Similar Items